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NaSi-1 is a Na1-sulfate cotransporter expressed on the
apical membrane of the renal proximal tubule and plays
an important role in sulfate reabsorption. To under-
stand the molecular mechanisms that mediate the regu-
lation of NaSi-1, we have isolated and characterized the
mouse NaSi-1 cDNA (mNaSi-1), gene (Nas1), and pro-
moter region and determined Nas1 chromosomal local-
ization. The mNaSi-1 cDNA encodes a protein of 594
amino acids with 13 putative transmembrane segments,
inducing high affinity Na1-dependent transport of sul-
fate in Xenopus oocytes. Three different mNaSi-1 tran-
scripts derived from alternative polyadenylation and
splicing were identified in kidney and intestine. The
Nas1 gene is a single copy gene comprising 15 exons
spread over 75 kilobase pairs that maps to mouse chro-
mosome 6. Transcription initiation occurs from a single
site, 29 base pairs downstream to a TATA box-like se-
quence. The promoter is AT-rich (61%), contains a num-
ber of well characterized cis-acting elements, and can
drive basal transcriptional activity in opossum kidney
cells but not in COS-1 or NIH3T3 cells. We demonstrated
that 1,25-dihydroxyvitamin D3 stimulated the transcrip-
tional activity of the Nas1 promoter in transiently trans-
fected opossum kidney cells. This study represents the
first characterization of the genomic organization of a
Na1-sulfate cotransporter gene. It also provides the ba-
sis for a detailed analysis of Nas1 gene regulation and
the tools required for assessing Nas1 role in sulfate ho-
meostasis using targeted gene manipulation in mice.
Sulfate is the fourth most abundant anion in mammalian
plasma, is present in nearly all cell types, and is essential for a
variety of metabolic and cellular processes (1). The largest
group of sulfoconjugates in mammals is sulfated proteoglycans,
which are required for normal structure and function of bone
and cartilage. Accordingly, three human congenital chondro-
dysplasias were recently shown to be caused by mutations in a
sulfate transport protein gene (DTDST),1 leading to undersul-
fation of proteoglycans in the extracellular matrix of bone and
cartilage, and associated developmental abnormalities (2–4).
Considering the importance of sulfate at a cellular and bio-
chemical level, it is likely that mechanisms regulating the
serum sulfate levels are essential for the maintenance of nor-
mal physiology. However, little is established about the molec-
ular factors that regulate sulfate homeostasis, and the physio-
logical consequence of a disturbance in sulfate homeostasis is
mostly unknown.
In mammals, the regulation of sulfate homeostasis is largely
determined by the kidney with the majority of the filtered
sulfate load reabsorbed in the proximal segment of the
nephron. Transepithelial transport of sulfate from the renal
lumen to the blood compartment involves entry through the
brush-border membrane (BBM) by a Na1-dependent transport
system, translocation across the cell and efflux across the ba-
solateral membrane by an anion exchange system (5). Early
transport studies in BBM vesicles suggested that Na1-sulfate
cotransport across the BBM is the rate-limiting step in the
overall sulfate reabsorptive process (6, 7). By expression clon-
ing, we isolated a cDNA (NaSi-1) from rat kidney encoding a
high affinity Na1-dependent sulfate transporter (8). NaSi-1
mRNA is expressed in kidney and small intestine and encodes
a glycosylated protein (8) that has been localized by immuno-
histochemistry to the BBM of proximal tubular cells (9).
Recently, factors known to regulate renal Na1-sulfate reab-
sorption were found to regulate NaSi-1 expression in the kid-
ney. Vitamin D was shown to modulate concomitantly serum
sulfate concentration, renal sulfate handling, and the expres-
sion (mRNA and protein levels) and activity of the NaSi-1
cotransporter (10). High sulfate intake in rats led to a reduction
in both NaSi-1 mRNA and protein (11), whereas low sulfate
intake (reduced methionine diet) led to an increase in both
NaSi-1 mRNA and protein (12). Thyroid hormone, growth hor-
mone, heavy metals, potassium intake, and anti-inflammatory
agents were also found to regulate NaSi-1 expression (13–17).
It is suggested that these modulators could alter serum sulfate
levels via the regulation of NaSi-1 expression in vivo, suggest-
ing that sulfate homeostasis is controlled, at least in part, by
NaSi-1. However, the underlying mechanisms involved in the
regulation of NaSi-1 expression by these factors, as well as
NaSi-1 contribution to body sulfate homeostasis, have yet to be
defined.
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In order to provide insights into the molecular mechanisms
underlying tissue-specific and hormonal regulation of NaSi-1
and its role in sulfate homeostasis, we have cloned and char-
acterized the mouse NaSi-1 cDNA and its corresponding gene.
This study represents the first characterization of the genomic
structure of a Na1-coupled sulfate transporter gene. We have
also determined the pattern of NaSi-1 expression in mouse
adult tissues, identified the existence of alternative tran-
scripts, determined its chromosomal localization, and demon-
strated that the transcriptional activity of the promoter region
is elevated in response to 1,25-(OH)2D3 stimulation in a tran-
siently transfected renal cell line.
EXPERIMENTAL PROCEDURES
PCR Amplifications and Sequencing—Oligonucleotides used during
this study are listed in Table I. The mouse NaSi-1 (designated mNaSi-1)
cDNA coding sequence was cloned using RT-PCR. Total RNA (5 mg)
isolated from mouse kidney cortex was reverse-transcribed and PCR-
amplified using primers derived from the rat NaSi-1 cDNA (designated
rNaSi-1) coding sequence (8). The PCR products were subcloned into
pCR 2.1 vector (Invitrogen) and sequenced in both directions. Semi-
quantitative PCR amplification of mNaSi-1 was performed by compar-
ing its abundance to b-actin. Preliminary optimization of the conditions
showed that coamplification of mNaSi-1 and b-actin transcripts was
occurring linearly through cycles 23–30. Total RNA treated with
RNase-free DNase I enzyme was reverse-transcribed, and PCR ampli-
fication (30 cycles) was performed using 0.4 mM mNaSi-1 primers
(FN252 and RN1220) and 0.1 mM b-actin primers. The identity of the
mNaSi-1 PCR-amplified products in each tissue was confirmed by re-
striction enzyme digestion. Fluorescence from ethidium bromide stain-
ing of each mNaSi-1 signal was compared with that of b-actin, by
calculating the ratio (fluorescence units of mNaSi-1/fluorescence units
of b-actin). Dye-termination sequencing was performed using the Big
DyeTM Termination kit (Perkin-Elmer) following the manufacturer’s
protocol, and gel separation was performed at the Australian Genome
Research Facility, the University of Queensland.
59- and 39-RACE—The 59- and 39 end of mNaSi-1 cDNA were isolated
using 59- and 39-RACE techniques, respectively, essentially as described
by Chen (18). For 59-RACE, primer RN137 was used to reverse-tran-
scribe mouse kidney total RNA and for a first round of PCR amplifica-
tion. After nested amplification using primer RN88, PCR products were
obtained and subcloned into pCR 2.1 vector. For 39-RACE, kidney total
RNA was reverse-transcribed using SuperScript II (Life Technologies,
Inc.) and an oligo(dT)/adapter primer. PCR amplification using Taq
DNA polymerase (Biotech International) was carried out using primer
FN1547. The 39-RACE technique was also used for identifying mNaSi-1
variants. In this case, total RNA from mouse kidney was reverse-
transcribed using display THERMO-RTTM (Display Systems Biotech)
reverse transcriptase, and PCR amplifications were performed using a
16:1 blend of Taq and Pfu (Promega) DNA polymerases with primers
FN-24, FN110, FN823, or FN1547. The 59-RACE technique was also
used to confirm the position of the transcription start site (see below). In
this case, primer RN535 was used for reverse transcription and first
round of PCR, and primer RN226 was used for nested amplification. In
addition, the display THERMO-RTTM reverse transcriptase was used to
permit the utilization of high temperatures (42 °C for 40 min and 65 °C
for 15 °C) avoiding an artificial termination due to the secondary struc-
ture of mRNA.
Xenopus laevis Oocytes and Transport Assays—Methods for handling
of oocytes, in vitro transcription, and transport assay have been de-
scribed previously (8, 19). Stages V and VI oocytes were injected with
either 50 nl of water (control) or 5 ng of mNaSi-1 cRNA using a Nanoject
automatic oocyte injector (Drummond Scientific Co.).
Northern and Southern Blot Analyses—Northern analysis of total
RNA (25 mg) from mouse tissues (Fig. 5) was performed as described
previously (20). Full-length mNaSi-1 cDNA was 32P-labeled by random
priming and used as a probe. After stripping, the membranes were
rehybridized with a 32P-labeled 1.3-kb mouse b-actin cDNA probe.
Mouse genomic DNA (10 mg) prepared from mouse liver was digested
with restriction enzymes (Fig. 3), separated on 0.7% agarose gels, and
capillary transferred to positively charged nylon membranes (Hybond
XL, Amersham Pharmacia Biotech). After UV-cross linking, the mem-
branes were hybridized (16–18 h at 65 °C) with a full-length 32P-labeled
mNaSi-1 cDNA probe in Church’s buffer (0.5 M Na2HPO4/NaH2PO4, pH
7.2, 7% SDS, 10 mM EDTA). The membranes were then washed to high
stringency and exposed to Kodak X-Omat AR5 film at 280 °C for 48 h.
Isolation and Characterization of Mouse Genomic Nas1 Clones—The
genomic clones were isolated from a l FIX II mouse (129sv strain)
genomic DNA library (Stratagene) using the method described by
Lardelli and Lendahl (21). Five positive l clones were purified and
further analyzed. Some large introns were isolated from mouse genomic
DNA using LA-PCR, as described elsewhere (22). Introns 1, 2, and 6–8
were amplified using primer pairs FN17/RN226, FN110/RN308,
FN390/RN687, FN665/RN909, and FN823/RN1020, respectively. Iden-
tity and further characterization of the l clones and PCR products were
confirmed by Southern analysis and/or direct sequencing of the coding
regions. Exon sizes were determined by nucleotide sequencing, and
intron sizes were determined by either nucleotide sequencing or esti-
mated from the size of corresponding PCR-generated DNA fragments
using exon-specific primers. Location of and sequences at intron/exon
boundaries of the Nas1 gene were determined by direct sequencing
using Nas1-specific oligonucleotides.
TABLE I
Oligonucleotides
Name Sequencea Positionb Strand
Sense Nas1-specific primers
FN-24 TGTTGAAGGCACCTGCTCAGG 224 Sense
FN17 ATGCTTTGGTCTATCGCCGCTTTC 17 Sense
FN110 GTGCCTACATCCTCTTTGTTATTG 110 Sense
FN252 CTTTCACCTTCTGCTAATTGGA 252 Sense
FN390 CACTGCCTTCTTATCTATGTGG 390 Sense
FN665 CAGTCACAGGAGCAAAATATCGG 665 Sense
FN823 GAATGTCGCTGCCTCCACTTTGG 823 Sense
FN1386 TCCTCTAGGTTCATTACCAGTTTG 1386 Sense
FN1547 TGCCTTCCACTCTCTGTACCTCA 1547 Sense
Antisense Nas1-specific primers
RN44 AGGAGAAAGCGGCGATAGAC 44 Antisense
RN88 TGATGAGAGGGAGTGGCAAGA 88 Antisense
RN137 ATGGCAATAACAAAGAGGATGT 137 Antisense
RN226 GTGAAGAACGCATGATCCCAAA 226 Antisense
RN308 TTCCATTTCTCTATTGATGTTGCT 308 Antisense
RN535 GGGCGGCAGATTCATTGAAATA 535 Antisense
RN687 CCGATATTTTGCTCCTGTGACTG 687 Antisense
RN909 GAGCCAAATCCAAGACAAAAGTAG 909 Antisense
RN1020 CCCAAGTTTTTCATATTCTT 1020 Antisense
RN1220 GTCATTTTTGTCAGTTTCTTGGC 1220 Antisense
RN1647 CATGTCAATGACTTTCAGGTGG 1647 Antisense
RN1989 AGGCGGGTAGATGCTCTTTGATTG 1989 Antisense
a Primers were designed either from the rat or the mouse NaSi-1 cDNA sequences and are written from the 59 to 39 direction.
b The number indicated refers to the nucleotide position within the mNaSi-1 cDNA sequence (A of ATG initiation codon defined as 11) where
the 59 end of the primer will anneal.
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Primer Extension Analysis—Primer extension analysis was per-
formed using protocols and reagents provided by Promega (primer
extension system). Briefly, two Nas1-specific primers located in exon 1
(RN44 and RN88) were end-labeled using T4 polynucleotide kinase and
[g-32P]dATP. Total RNA (10 mg) was mixed with 0.1 pmol of the labeled
primer, denatured 5 min at 90 °C, and incubated at 55 °C for 16 h in
hybridization buffer (0.4 M NaCl, 1 mM EDTA, 40 mM PIPES, pH 6.4,
80% formamide). After reverse transcription using avian myeloblastosis
virus-reverse transcriptase, the labeled cDNAs were separated through
a 6% polyacrylamide gel. HinfI-fx174-digested DNA was end-labeled
and used as a molecular weight marker. The gel was dried and exposed
to Kodak X-Omat AR5 film for 48 h at 280 °C.
Chromosomal Localization by Radiation Hybrid—Fine mapping of
Nas1 was undertaken using the T-31 Radiation Hybrid Panel of the
mouse genome (Research Genetics). Primers used for screening were
FN1386 and RN1647, generating an intense 1.5-kb band from mouse
genomic DNA and a faint 950-bp band from Chinese hamster DNA. The
panel was screened twice using these primers and a third time using
primers FN1547 and RN1989. Data analysis was performed by the
Jackson Laboratory Mouse Radiation Hybrid Data Base.
Plasmid Construction, Cell Culture, and Transient Transfections—
Three fragments containing 3229, 1203, and 457 bp of Nas1 59-flanking
sequence, respectively, were PCR-amplified from the lP2 clone (Fig.
4A), subcloned into pCR2.1 vector, and sequenced. These fragments
were then inserted upstream of a luciferase reporter gene in a promot-
erless luciferase expression vector (pGL3-Basic, Promega) by restriction
enzyme digestion and ligation. Plasmids were designated pNas1-3229,
pNas1-1203, and pNas1-457, respectively. The 1203-bp promoter frag-
ment was also cloned in reverse orientation and designated pNas1-
1203R. Correct insertion and sequence were verified by enzyme restric-
tion digestion and sequencing. COS-1 and NIH3T3 cells were cultured
in Dulbecco’s modified Eagle’s medium (Life Technologies, Inc.) with
10% (v/v) fetal bovine serum (Life Technologies, Inc.). OK cells were
maintained in Ham’s F12/Dulbecco’s modified Eagle’s medium (1:1)
containing 10% fetal bovine serum. At 80% confluence, cells were co-
transfected using LipofectAMINETM 2000 reagent (Life Technologies,
Inc.), with 0.8 mg of the Nas1 gene promoter-luciferase reporter plasmid
and 0.8 mg of pRSVbGal plasmid (gift of Dr. M. Waters, University of
Queensland) as an internal control for transfection efficiency. Incuba-
tion with plasmids and LipofectAMINE was carried out for 24 h in
normal growth medium, as recommended by the manufacturer. Con-
trols were performed by transfection with pGL3-Basic (promoter-less
plasmid) and pGL3-Control (containing the SV40 promoter). In exper-
iments involving vitamin D, cells were cotransfected with 0.2 mg of a
VDR expression vector alone or together with 0.2 mg of a human RXRa
expression vector (VDR/pSG5 and RXR/pSG5 plasmids, respectively;
generous gift from Dr. John White, McGill University). The VDR and
hRXRa expression plasmids were cotransfected to ensure that a suffi-
cient concentration of receptor was available for binding to the overex-
pressed Nas1 gene. Incubation with plasmids and LipofectAMINE was
carried out for 24 h, after which the medium was replaced by fresh
Dulbecco’s modified Eagle’s medium containing 10% fetal bovine serum
with varying concentrations of 1,25-(OH)2D3 for an additional 24 h.
Cells were then harvested in cell lysis buffer, and the lysate was
assayed for luciferase and b-galactosidase activities using protocols and
reagents provided by Roche Molecular Biochemicals. Luciferase activity
was measured using a Trilux 1450 Microbeta (Wallac) luminometer.
Data Presentation and Statistics—Data are shown as means 6 S.D.
Statistical significance was determined by unpaired Student’s t test,
with p , 0.05 considered significant. For the transport kinetic studies
in oocytes, the Michaelis-Menten and generalized Hill equations were
used to calculate Km and Vmax values using non-linear regression.
RESULTS
Mouse NaSi-1 cDNA Cloning and Expression—The mouse
Na1-sulfate cotransporter cDNA, mNaSi-1, was cloned using a
combination of RT-PCR and 59- and 39-RACE techniques. The
mNaSi-1 cDNA is 2246 bp long, with 28 bases of 59-UTR, an
open reading frame of 1782 bases, and 436 bases of 39-UTR.
The 39-UTR contains a polyadenylation signal (AATAAA) at
position 2180. The open reading frame encodes a protein of 594
amino acids (Fig. 1A) with a calculated molecular mass of 66.1
kDa, containing 13 putative transmembrane domains, pre-
dicted by the TopPred2 program (23). The mNaSi-1 protein
contains one potential protein kinase A (Thr404) and five po-
tential protein kinase C (Ser213, Thr218, Ser230, Thr322, and
Thr422) phosphorylation sites (Fig. 1A). Consensus sequences
for N-glycosylation were found at Asn positions 140, 174, and
590 (Fig. 1A). Alignment of the mouse and rat NaSi-1 amino
acid sequences shows 93.6% identity and 96% similarity. Nu-
cleotide sequence identity is 91% between mouse and rat
NaSi-1. When this work was initiated, no ESTs with homology
to mNaSi-1 were identified. At the submission of this manu-
script, a search in the EST data base identified approximately
50 murine ESTs from kidney, all identical to mNaSi-1. Homol-
ogy searches using BLAST (24) and PSI-BLAST (25) revealed
significant homology to 22 other proteins (Fig. 1B), although
the closest relatives are the recently reported human Na1-
sulfate cotransporter SUT-1 (49% identity (26)) and the Na1-
dicarboxylate transporters sharing ;32–43% protein sequence
identity with mNaSi-1. Of particular interest is a consensus
pattern previously established for Na1-coupled symporters
(PROSITE PS01271) known as the Na1-sulfate signature,
present at amino acids 522–538 in the mNaSi-1 protein con-
taining a very high degree of homology with other related
proteins (Fig. 1B).
To determine the functionality of the isolated clone, we in-
jected mNaSi-1 cRNA into Xenopus oocytes followed by
[35S]sulfate radiotracer uptake assay. Sulfate uptake in
mNaSi-1-cRNA-injected oocytes was Na1-dependent and
showed typical Michaelis-Menten saturation, with a calculated
Km value for sulfate of 0.20 6 0.06 mM and Vmax of 49.2 6 4.1
pmol/h (data not shown), in agreement with the BBM Na1-
sulfate cotransporter (5). mNaSi-1 mRNA expression was
screened by RT-PCR in 23 murine tissues (Fig. 2). An amplified
mNaSi-1 fragment was obtained in RNA from kidney, duode-
num/jejunum, ileum, and colon. Lower levels of mNaSi-1
mRNA expression were observed in cecum, testis, adrenal, and
adipose tissue. By normalizing the mNaSi-1 mRNA signal to
b-actin, the relative abundance of mNaSi-1 in kidney and ileum
was found to be similar and approximately twice as high as
those found in duodenum/jejunum and colon (Fig. 2B; n 5 3).
The physiological importance of the low level of expression of
mNaSi-1 found in testis, adrenal, and adipose tissue remains to
be determined.
Genomic Organization of the Mouse Na1-Sulfate Cotrans-
porter Gene, Nas1—Southern blotting was used to estimate the
size and complexity of the gene encoding mNaSi-1, designated
Nas1 (Fig. 3). Results show that the estimated size of the Nas1
gene was approximately 45 kb, which was lower than the
actual size of the Nas1 gene determined from genomic cloning
(see below). This was due both to the presence of comigrating
bands and large introns that did not hybridize with the cDNA
probe. Blots washed at both high and low stringency gave
similar results, suggesting that Nas1 is a single copy gene.
Screening of a genomic l phage library led to the isolation of
five l Nas1 clones containing the 59-flanking region and most of
the Nas1-coding region (Fig. 4A). Introns 1, 2, and 6–8 not
present in the l clones were obtained using LA-PCR (Fig. 4A).
The l clones and PCR-amplified introns overlapped, covering a
80-kb region comprising the entire Nas1 gene (Fig. 4A). South-
ern analysis of the Nas1 genomic clones was consistent with
the data obtained from Southern blotting of mouse genomic
DNA and confirmed that Nas1 is a single copy gene. The
resulting exon-intron organization of the mouse Nas1 gene is
shown in Fig. 4B. The Nas1 spans ;75 kb and contains 15
exons. The translation initiation site is present in exon 1. Exon
sizes range from 49 to 188 bp, except for exon 15, which is 555
bp and contains the TGA stop codon (Fig. 4C and Table II).
Intron sizes range from 70 bp to 15 kb (Table II). All exon-
intron boundaries conform to canonical splice donor and accep-
tor consensus sequences, and the codon phase usage is mainly
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0 or II (Table II). Comparison of predicted protein transmem-
brane domains to exon border structure showed that each pre-
dicted transmembrane segment is encoded by a separate exon,
with the exception of transmembrane domains 10 and 11,
which are encoded by the same exon (exon 13). In addition,
splicing mostly occurred near membrane/aqueous transitions
(Fig. 4D).
Mapping of Nas1 to Mouse Chromosome 6—Nas1 was
mapped by analysis of the data from the T-31 Radiation Hybrid
panel in The Jackson Laboratory Mouse Radiation Hybrid data
base. The data placed Nas1 on mouse chromosome 6 in the
most likely position between marker D6Mit170 (LOD score
20.8) and D6Mit380 (LOD score 11.2). Nas1 is 2.3 centi-rays
distal to D6Mit170, which has been assigned map positions of
4.4 centimorgans (MIT) and 4.0 centimorgans (MGD and Chro-
mosome Committee). The Nas1 gene maps very close to the
calcitonin receptor gene, which has been assigned a position of
4.5 centimorgans (MGD and Chromosome Committee) in
FIG. 1. Sequence alignments of
mNaSi-1. A, comparison of the deduced
amino acid sequences of mNaSi-1 and
rNaSi-1 (8). Amino acids that are identi-
cal are depicted with gray shading. Puta-
tive transmembrane domains (TM1–
TM13) are underlined. Potential
phosphorylation (<, protein kinase C; l ,
protein kinase A) and N-glycosylation (Y)
sites are labeled. The Na1-sulfate signa-
ture is boxed (see B). B, multiple sequence
alignment of the Na1-sulfate signature
PROSITE pattern among mNaSi-1 homo-
logues, with GenBankTM accession num-
bers indicated. The PROSITE consensus
pattern is indicated at the bottom of the
alignment; amino acids that differ from
this consensus sequence are circled. Se-
quence alignments were made using the
ClustalW and MacVector programs.
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mouse and 7q21.3-q21.3 in human.
Alternative Polyadenylation and Splicing of the Nas1
Gene—By using Northern blot analysis, two major transcripts
of equal intensity (2.2 and 2.5 kb) were detected in kidney,
ileum, duodenum/jejunum, and colon but not in liver (Fig. 5A),
confirming the RT-PCR data (Fig. 2). Normalizing the mNaSi-1
mRNA signal with b-actin showed that renal and ileal mNaSi-1
transcripts were of similar abundance, in agreement with RT-
PCR data (Fig. 2). Whereas the 2.2-kb transcript most probably
corresponds to the 2246-bp cDNA fragment characterized
above, the larger transcript is most likely derived from alter-
native polyadenylation, as previously shown for the rNaSi-1
transcripts (8, 27). To test this, we performed 39-RACE on total
RNA from mouse kidney (Fig. 5B). Two bands were obtained
using primers FN110, FN823, and FN1547 (Fig. 5B, lanes 2–4).
Sequencing analysis showed that the smaller band corre-
sponded to the 2246-bp mNaSi-1 cDNA, whereas the larger
band contained an additional 254 nucleotides at the 39 end,
generating a 2500-bp cDNA fragment containing a polyadenyl-
ation signal at position 2437. Sequence comparison between
the 2.5-kb clone and the genomic l3 clone showed absence of
introns in the 39-UTR. In addition to the 2.2- and 2.5-kb clones,
we could also amplify an additional faint band at 2.1 kb using
a sense primer further upstream (Fig. 5B, lane 1). This frag-
ment was 100% identical to the 2.2-kb cDNA, with the excep-
tion of a missing 129-bp region, corresponding to exon 2 se-
quence (Fig. 5C). To determine the functionality of these clones,
we injected the corresponding cRNAs into Xenopus oocytes.
Both the 2.2- and 2.5-kb clones induced significant Na1-sulfate
cotransport (at a similar rate), whereas the 2.1-kb clone showed
an activity comparable to water-injected oocytes (Fig. 5D).
Transcription Initiation Site and Nucleotide Sequence of the
Nas1 59-Flanking Region—To identify the transcription start
site, primer extension assays were performed. A single major
product of 70 and 114-nucleotides was identified using primers
RN44 and RN88, respectively (Fig. 6A). This located the tran-
scription start site, designated 11, at 26 bp upstream from the
translation initiation ATG codon (Fig. 6C). To confirm these
data, we performed 59-RACE, which gave rise to a 277-bp band
(Fig. 6B). Sequence analysis of this fragment confirmed the
primer extension findings, locating the transcription start site
28-bp upstream from the ATG codon (Fig. 6C).
A 3229-bp region of the Nas1 promoter has been isolated and
sequenced (Fig. 7). This region was found to be A 1 T-rich
(61%). The center of an atypical TATA sequence, TATTTAA, is
located 29 bp upstream of the transcription start site. A clas-
sical CAAT box consensus sequence is present at position 291
on the negative strand. However, a canonical TATA box and
CAAT box are positioned further upstream at 2201 and 2424,
respectively, but are considered too far from the transcription
start site to have promoter function. No GC box motif or Sp1-
binding sites were detected. A repeated GA-rich region of un-
known function was found from position 2218 to 2410. The
Nas1 promoter contains a number of potential cis-acting ele-
ments recognized by well characterized transcription factors
that may play a role in the basal or chronic regulation of the
Nas1 gene. These include two AP-1 sites, one AP-2 site, one
AP-4 site, two CAAT/enhancer-binding protein (C/EBP) bind-
ing sites, three Oct-1 sites, three NF-Y sites, and two NFAT
FIG. 2. Tissue distribution of mouse
Na1-sulfate cotransporter. A, total
RNA from various mouse tissues (indicat-
ed at the top) was reverse-transcribed us-
ing an oligo(dT) primer and PCR-ampli-
fied using mNaSi-1 (FN252 and RN1220,
upper bands) and b-actin (lower bands)
primers. An aliquot of each PCR reaction
was electrophoresed on 1.2% agarose gels
and visualized with ethidium bromide. A
water blank is shown. B, densitometric
analysis of mNaSi-1 RT-PCR-amplified
mRNA derived from three separate exper-
iments. Data are shown as mean 6 S.D.
FIG. 3. Southern blot analysis of mouse genomic DNA. Mouse
liver DNA (10 mg) was digested with BamHI, EcoRI, EcoRV, HindIII, or
PstI, as indicated, electrophoresed on a 0.7% agarose gel, transferred to
a nylon membrane, and hybridized with a full-length 32P-labeled
mNaSi-1 cDNA probe.
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sites. There were many GATA-1-binding sites, located at nu-
cleotides 2153, 2400, 2605, 2682, 2928, 2948, 21222,
21348, 22088, and 23030. Consensus sequences for the bind-
ing of other transcription factors activated by mitogenic or
differentiation signals (c-Ets-1, Sox-5, hepatic nuclear factor 4,
upstream stimulating factor, FREAC4, and Pit-1) are also pres-
ent (Fig. 7). However, the evaluation of many of these sites in
relation to known Nas1 functions will require additional
studies.
Structure of Putative Steroid-Thyroid Hormone-responsive
Elements in the Nas1 Promoter—Three regions, named A, B
and C, containing direct repeat-like sequences similar to ste-
roid-thyroid hormone-responsive elements were found (Fig. 7).
Within the region A (22549 to 22515), the sequence 59-AGT-
TCAgaaTGTCCT-39 bears strong resemblance to the consensus
inverted repeat sequence (59-AGGTCA—TGACCT-39) of TREs.
This same sequence also had similarities to the consensus core
binding motif (59-(A/G)G(G/T)TCA-39) of VDREs as well as the
mouse osteopontin VDRE (28). Within the same region, the
sequences 59-AGCTCActctgtAGTTCA-39 and 59-AGTTCAgaat-
gtCCTTGA-39 show strong similarities with DR6-type and pal-
indromic type consensus VDREs (29), respectively. Region B
(2525 to 2508) contains a consensus DR6-type structure (59-
GGTTCAtcaaaaGGGGCA-39). Slightly downstream, region C
(2496 to 2468) contains a DR3-type structure (59-GTGTGAa-
caAAGTCA-39) with similarities to rat osteocalcin (30) and rat
calbindin (31) VDREs, as well as a second DR3-type structure
(59-AGTTAAtttCATTCA-39) with similarities to mouse os-
FIG. 4. Organization of the mouse Na1-sulfate cotransporter Nas1 gene. A, genomic Nas1 clones and LA-PCR products obtained are
indicated. B, genomic structure of the mouse Nas1 gene. Top, partial restriction map of Nas1 gene. E, EcoRV; H, HindIII; B, BamHI. Middle, Nas1
gene organization. The horizontal line indicates gene introns, and vertical lines represent exons (numbered 1–15). The position of introns was
determined by sequencing across exon/intron boundaries of genomic fragments and LA-PCR products. Bottom, scale in kb. C, exons 1–15 are
represented by boxes. The white portions of the exons identify the protein-coding sequences, and the size of each exon is indicated in bp. The
translation initiation site is present in exon 1. The gray portions of the exons represent the untranslated regions. D, a comparison of the predicted
13 transmembrane spanning domain models and the exon border structure. Gray boxes indicate predicted transmembrane domains of the protein.
The programs used for predicting the transmembrane spanning domains were TopPred2 (23), TMPred (55), and Sosui (56).
TABLE II
Exon/intron organization of the mouse Nas1 gene
Intron
number Location 59 splice donor
a Intron sizeb 39 splice acceptora Amino acidc Codonphased
Exon
number Exon size
bp bp
1 99 ACCAAG/gtaagcaagc. . . 15,000 . . .ccctttgcag/GAAGCA Lys 0 1 127
2 228 TCACAG/gtaacataat. . . 12,500 . . .gcaatttcag/GTGGCT Gln 0 2 129
3 365 AGCCTG/gtgagtatta. . . 2,500 . . .ctcgtttcag/GCTGAC Trp II 3 137
4 553 TTGATG/gtatcatgta. . . 600 . . .tatcttacag/AAACTG Glu I 4 188
5 611 TCCAGG/gtaaagacta. . . 70 . . .tatgtttcag/AAGCAG Gly II 5 58
6 660 GAAAAG/gtacattaca. . . 13,500 . . .ttgattacag/AATGCA Lys 0 6 49
7 794 GATCTT/gtataaagct. . . 10,000 . . .cttattgcag/CTCTGA Phe II 7 134
8 932 ATTCGA/gtaagtagac. . . 3,500 . . .tctctttcag/CTTTAA Asp II 8 138
9 1028 AATGAG/gttaaaattg. . . 560 . . .tcttccacag/GTATCA Arg II 9 96
10 1130 TTCAGA/gttgagtatc. . . 3,100 . . .tatttttcag/GTACCC Glu II 10 102
11 1237 AAATTA/gttgagtatc. . . 2,400 . . .tattttgcag/TTGCTT Ile I 11 107
12 1347 TGTCAG/gtaatgctca. . . 4,800 . . .tgtattgtag/GTATCA Gln 0 12 110
13 1509 CCTTTG/gtgagtatga. . . 1,250 . . .tccatgccag/GCTGAA Leu 0 13 162
14 1647 GACATG/gtaagtcagc. . . 1,500 . . .tgttactaag/GTTAAA Met 0 14 138
15 555
a Exon sequences are indicated by uppercase letters and intron sequences by lowercase letters.
b Intron size was determined by restriction analysis, direct sequencing for small introns, and by estimating the size of PCR amplification
products for large introns.
c Amino acids encoded at the splice sites are indicated.
d Introns that do not split codon triplets are indicated by phase 0, interruption after the first nucleotide by phase I, and interruption after the
second nucleotide by phase II.
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teopontin VDRE (28). Overlapping the two DR3, is a DR4-type
structure (59-AAGTCAgttaATTTCA-39) with similarities to
mouse Pit-1 VDRE (32). In addition to these three regions, five
GREs are detected at position 1621, 1377, 1248, 2580, and
2792. These motifs are similar to the consensus inverted pal-
indromic GRE sequence 59-AGAACAnnnTGTTCT-39 that is
distinct from the TRE/VDRE core binding motif (33). Within
this consensus GRE, the core binding motif TGTTCT is gener-
ally well conserved, whereas the left-most hexanucleotide se-
quence can be quite variable (33).
Transcriptional Activity of the Nas1 Promoter—To determine
whether the 59-flanking region of the Nas1 gene can initiate
basal transcription, reporter constructs were made with the 59
upstream region of Nas1 fused to a luciferase reporter gene and
transfected into OK, COS-1, and NIH3T3 cells (Fig. 8). In OK
cells, the construct containing the Nas1 sequence 2457 to 170
(pNas1-457) was able to induce the highest luciferase expres-
sion when compared with constructs containing more down-
stream sequences of the Nas1 promoter (pNas1-3229 and
pNas1-1203), suggesting the possible presence of downstream
negative regulatory elements (Fig. 8). The luciferase activity
driven from the sequence 21203 to 170 inserted in the reverse
orientation (pNas1-1203R) was not significantly different from
the promoterless pGL3 vector. In contrast to OK cells, none of
the Nas1 promoter fragments were able to drive expression of
the luciferase gene in COS-1 or NIH3T3 cells (Fig. 8).
Transactivation by VDR, RXR, and 1,25-(OH)2D3—The po-
tential transcriptional activity of the Nas1 promoter in re-
sponse to 1,25-(OH)2D3 was initially tested using the pNas1-
1203 construct (Fig. 9A). Cotransfection of pNas1-1203 and the
VDR expression vector into OK cells did not result in increased
luciferase activity, when compared with transfection with
pNas1-1203 alone. In contrast, in OK cells expressing both the
VDR and hRXRa, the increase in luciferase activity was 8.9-
fold higher than with activation of pNas1-1203 alone. Under
these conditions, in the presence of 0.5 and 50 nM 1,25-(OH)2D3,
the promoter activity was further increased by 1.8- and 4.1-
fold, respectively (Fig. 9A). Similar experiments were per-
formed for the pNas1-3229, pNas1-1203, pNas1-457, and
pNas1-1203R constructs, and the effect of 1,25-(OH)2D3 in OK
cells coexpressing the VDR and hRXRa is summarized in Fig.
9B. When transfected with pNas1-3229 or pNas1-1203 con-
structs, the luciferase activity increased markedly upon expo-
sure of cells to 0.5 or 50 nM 1,25-(OH)2D3. In contrast, the
luciferase activity in OK cells transfected with pNas1-457 or
pNas1-1203R was not affected by 1,25-(OH)2D3 (Fig. 9B).
DISCUSSION
NaSi-1 is a high affinity Na1-sulfate cotransporter present
on the BBM of the renal proximal tubule (9) and ileum (27). The
FIG. 5. Nas1 transcription products. A, Northern analysis of total
kidney mRNA. Top panel, total RNA (25 mg) from mouse kidney, ileum,
duodenum/jejunum, colon, and liver was hybridized to a full-length
2.2-kb mNaSi-1 cDNA probe. Lower panel, after stripping, the same
membrane was hybridized to a 1.3-kb b-actin cDNA probe, as a control
for RNA quality and loading. Exposure times were 24 h for mNaSi-1
probe and 1 h for b-actin probe. B, 39-RACE. Total RNA was reverse-
transcribed with an oligo(dT)/adapter primer and PCR-amplified using
an antisense adapter primer and sense mNaSi-1-specific primer as
indicated. C, structure of the Nas1 transcription products. Two forms of
mNaSi-1 mRNA were derived from alternative polyadenylation (2.2 and
2.5 kb), the third form was derived from alternative splicing and lacked
exon 2 (2.1 kb). Exons (E) are indicated by boxes. D, mNaSi-1 cDNA
variants were subcloned, in vitro transcribed, and either water (open
bars) or cRNA (filled bars) corresponding to each transcript were in-
jected into Xenopus oocytes (8–10 oocytes per condition). 35SO422 uptake
was performed day 3 post-injection at room temperature for 30 min, in
the presence of sodium. Data are shown as mean 6 S.D. *, p , 0.01
when compared with water-injected oocytes.
FIG. 6. Mapping the transcription start site of Nas1 using
primer extension and 5*-RACE. A, primers RN44 and RN88 (see C)
were mixed with either no RNA (lanes 6 and 10) or with 10 mg of total
RNA prepared from mouse kidney or liver, as indicated. A control
primer extension reaction was also included. The primers were ex-
tended with avian myeloblastosis virus-reverse transcriptase at 42 °C
for 30 min. The reaction products were size-fractionated on a 6% dena-
turing polyacrylamide gel, followed by exposure to film for 1.5 (lanes 1
and 2) or 48 h (lanes 3–10). The sizes of the primer extension products
were determined by their migration relative to a molecular weight
marker (HinfI-digested fx174, labeled with [g-32P]dATP). B, total RNA
(5 mg) isolated from mouse kidney was reverse-transcribed using primer
RN535. After two rounds of PCR amplification with primer RN226 (see
C), a 277-bp fragment was obtained (lane 2). DNA size markers (lane 1)
and a PCR blank (lane 3) are shown. C, 59-flanking sequence of the
Nas1 gene. Primers used in primer extension and 59-RACE experiments
are indicated. The ATG translation initiation site is boxed. The tran-
scription start sites as mapped by primer extension (defined as position
11) and 59-RACE are indicated by the arrow and asterisk, respectively.
Identical results were obtained in two additional experiments.
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tissue distribution, hormonal regulation, and characteristics of
expressed activity of NaSi-1 suggest that this transporter may
play a crucial role in the maintenance of sulfate homeostasis.
Our report describes the first characterization of the genomic
structure and fine chromosomal localization of a mammalian
Na1-coupled sulfate transporter gene. We also demonstrate a
FIG. 7. Nucleotide sequence of the
5* region of the Nas1 gene. Nucleotide
11 denotes the transcription start site
and is marked by an arrow. Amino acid
sequence corresponding to exon 1 is in
boldface type and indicated below the cod-
ing strand. The translation initiation
ATG codon is double underlined. The
TATA and CAAT boxes, as well as puta-
tive transcription factor binding motifs,
with core sequence underlined, are boxed.
Only the best potential binding motif for
each of the transcription factors shown is
boxed (core similarity .0.9, matrix simi-
larity .0.85). Regions containing poten-
tial steroid/thyroid-responsive elements
are underlined and labeled A–C, respec-
tively. The GA-rich region of unknown
function is in italic uppercase. AP-1, asso-
ciated protein 1; AP-2, associated protein
2; AP-4, associated protein 4; C/EBP,
CAAT/enhancer-binding protein; c-Ets-1,
c-Ets-1 proto-oncogene product; GATA-1,
GATA binding factor 1; GRE, glucocorti-
coid-responsive element; HNF4, hepatic
nuclear factor 4; FREAC4, forkhead re-
lated activator 4; NFAT, nuclear factor of
activated T cells; NF-Y, nuclear factor Y;
Oct-1, octamer factor 1; Sox-5, SRY-re-
lated HMG box; USF, upstream stimulat-
ing factor. The analysis of the transcrip-
tion factor-binding sites was performed
using the MatInspector program (57).
FIG. 8. Transcriptional activity of
the Nas1 promoter region. OK (filled
bars), COS-1 (gray bars), and NIH3T3
(open bars) cells were transiently trans-
fected using LipofectAMINE 2000 with
0.8 mg of reporter vector containing the
luciferase gene under the control of the
Nas1 promoter and 0.8 mg of the
pRSVbGal control plasmid. Transfected
cells were harvested after 24 h and as-
sayed for luciferase and b-galactosidase
activity. Data are shown relative to activ-
ity observed with the pGL-3 vector (pro-
moterless vector). The pGL-3 control vec-
tor (containing the SV40 promoter) was
used as a positive control. Data are
means 6 S.D. from triplicate determina-
tions, and the results are representative
of three separate experiments.
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cell-specific transcriptional activation of Nas1 expression as
well as a transactivation of the Nas1 gene expression by
1,25-(OH)2D3.
The characteristics of expressed activity of mNaSi-1 protein
in Xenopus oocytes, as well as the overall pattern of mNaSi-1
mRNA tissue distribution, support the finding that we have
cloned the mouse proximal tubular BBM Na1-sulfate cotrans-
porter (34). Both kinetic data and tissue distribution were very
similar to the rat NaSi-1 (8). Three mNaSi-1 cDNA variants
were identified in mouse kidney mRNA. The two main tran-
scripts (2.2 and 2.5 kb) could be detected by Northern analysis,
and comparison with the genomic sequence showed that they
were derived from alternative polyadenylation, as shown for
the two rNaSi-1 transcripts (2.3 and 2.9 kb) detected in rat
kidney mRNA (8, 27). The third mNaSi-1 variant (2.1 kb) was
considered to be the result of alternative splicing of exon 2. This
alternative spliced version of mNaSi-1 could not be detected on
Northern blots and did not show significant sulfate transport
when injected in Xenopus oocytes, despite the fact that no
frameshift was introduced by exon 2 splicing. A possible expla-
nation for the loss of function is that deletion of exon 2, encod-
ing transmembrane segment 2, would lead to an inverted mem-
brane topology of the protein due to the lack of one
transmembrane segment. Alternatively, the removal of trans-
membrane segment 2 could disrupt the native signal anchor
sequence and perturb the sequential mechanism of membrane
insertion and folding (35). In view of our data, we conclude that
the alternatively spliced mRNA, detected by RT-PCR only,
represents a rare transcript that is unlikely to have significant
biological relevance.
The mNaSi-1 protein secondary structure model of 13 trans-
membrane segments contrasts with the secondary structure
prediction of rNaSi-1 protein, which was initially predicted to
contain 8 transmembrane segments (8). The difference is most
probably due to the difference in the prediction method, which
was previously based on hydropathy analysis. The new predic-
tion was performed using the TopPred2 program (23), featuring
a more precise analysis of the hydropathy data and taking into
account the inside positive rule (36). Consensus sequences for
N-glycosylation were found at positions 140, 174, and 590;
however, according to the 13 transmembrane helices model,
only Asn590 is suggested to be extracellular and thus possibly
glycosylated. This is consistent with the study of Pajor and Sun
(37) showing glycosylation of rabbit NaDC-1 to only occur on
Asn578. However, although the 13 transmembrane domain
model is likely to represent a better prediction than the 8
transmembrane domain model, additional work is needed to
validate this model.
The Nas1 gene contains 15 exons distributed among 75 kb
without obvious pattern of exon organization. Although exons
encoding transmembrane domains were similar in size, no
sequence identity was detected at the nucleotide or amino acid
level between them (data not shown), suggesting that these
exons did not arise through duplication events. The recently
identified SUT-1 transporter shares the highest sequence iden-
tity with mNaSi-1; however, its genomic structure is presently
unknown and thus no comparison was possible. The genomic
structure of human NaDC-1 gene was recently reported and
appeared to be significantly different from the Nas1 gene,
containing 12 exons distributed over 23.8 kb of genomic DNA
(38). Similarly, the genomic structure of sulfate/anion exchang-
ers differ considerably from the Nas1 gene. The human CLD
gene comprises of 21 exons spanning 39 kb (39), whereas the
rat Dtdst gene contains only 5 exons spanning approximately
FIG. 9. Regulation of the mouse
Nas1 promoter by VDR/RXR and 1,25-
(OH)2D3. A, a vector containing 1.2 kb of
Nas1 promoter sequence (pNas1-1203,
0.8 mg) was transfected into OK cells with
or without the VDR (0.1 mg) or hRXRa
(0.1 mg) expression vector, as indicated.
After 24 h, cells were incubated with 1,25-
(OH)2D3 (0.5 or 50 nM) or ethanol as con-
trol for an additional 24 h before being
harvested and assayed for luciferase and
b-galactosidase activity. Results are rep-
resented as fold induction in OK cells as
compared with pNas1-1203 alone. **, p ,
0.01 when compared with transfection
with pNas1-1203 alone. B, OK cells were
transfected with 0.8 mg of a Nas1 reporter
plasmid (pNas1-3229, pNas1-1203,
pNas1-457, or pNas1-1203R, as indicat-
ed), 0.1 mg of VDR expression vector, and
0.1 mg of hRXRa expression vector. After
24 h, cells were incubated with 1,25-
(OH)2D3 (0.5 nM or 50 nM) or ethanol as
control for an additional 24 h before being
harvested. Results are expressed as fold
induction by 1,25-(OH)2D3, as compared
with no 1,25-(OH)2D3 treatment. Data are
means 6 S.D. from triplicate determina-
tions and are representative of two sepa-
rate experiments. *, p , 0.05 and **, p ,
0.01 when compared with no 1,25-
(OH)2D3 treatment.
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20 kb (40). In contrast, despite sharing no homology with
mNaSi-1 cDNA, the human Na1-glucose SGLT1 transporter
shares a comparable gene structure with Nas1 consisting of 15
exons distributed among 72 kb (41). Particularly, the exon sizes
and their distribution are very similar to that of Nas1. More-
over, most of the 35 members of the SGLT1 gene family share
a common core structure of 13 transmembrane helices (42), as
is the case for Nas1. Superimposing the Nas1 exon boundaries
on the mNaSi-1 protein secondary structure model shows that
splicing frequently occurs near membrane/aqueous transitions,
as is also observed with the SGLT1 gene (41) and other genes
encoding membrane proteins, such as the murine band 3 (43),
human skeletal muscle sodium channel (44), and GLUT1-,
GLUT2-, and GLUT4-facilitated glucose transporters (45). It
remains to be elucidated whether the similarities between the
two Na1-cotransporters, SGLT1 and Nas1, are the result of a
possible common evolutionary origin.
The Nas1 gene was mapped to mouse chromosome 6, close to
marker D6Mit170, which has been assigned a map position of
4.0 centimorgans. The mouse chromosome 6 region from cen-
tromere to map position 28 centimorgans is a region of con-
served synteny with human chromosome 7. It contains 46 iden-
tified genes whose human homologues map to chromosome 7,
between regions q14 and q35. Within this region, only one gene
(centromere autoantigen E gene) maps to another chromosome
(4q24-q25). Altogether these linkage data suggest that the hu-
man homologue of the Nas1 gene most likely resides on human
chromosome 7q. Interestingly, the human SUT-1 gene, which
displays 49% amino acid identity to mNaSi-1, was mapped to
7q33, close to 7q32 (26). Due to their high protein identity and
possible chromosomal colocalization, studies in humans are
warranted to determine whether the SUT-1 and NAS1 genes
could have derived from a gene duplication event. A similar
situation was described previously for the DRA and PDS genes,
encoding for sulfate and chloride anion exchangers sharing
45% homology and both residing on human chromosome 7q21–
31.1 (46).
Transcription initiation of the Nas1 gene occurs at a single
site and is under the control of an atypical TATA box located 29
bp upstream of 11, yielding mRNA with a short 26-bp 59-UTR.
The core and flanking residues of the atypical TATA box,
TTAT0TTAAC, differ from the extended canonical sequence
(G/C) TAT0A(A/T)AA(G/A) by having a T in the 23 position, a
T in the 11 position, and a C in the 15 position. Nonetheless,
a recent study showed that these bases can be present in these
positions but at low frequencies (8, 8, and 11%, respectively)
(47). Interestingly, the promoter region is AT-rich (61%), rather
than GC-rich, a feature that, together with the unique tran-
scription start site, has been observed for genes that are regu-
lated during development and differentiation (48). The AT-rich
feature is also consistent with the restricted pattern of Nas1
gene expression since GC-rich promoters are commonly asso-
ciated with widely expressed “housekeeping” genes. The role of
Nas1 during development and differentiation is yet unknown.
However, it is interesting to note the presence of multiple
binding sites for Sox-5, a transcription factor that has critical
roles in the regulation of numerous developmental processes;
upstream stimulating factor (USF), a ubiquitous factor in-
volved in development; and hepatic nuclear factor 4 (HNF-4), a
thyroid hormone receptor-like factor expressed in kidney from
day 10.5 post-coitum and involved in development. In addition,
two potential binding sites for FREAC-4, a transcription factor
predominantly expressed in kidney (49) and having important
roles in embryonic development, as well as regulation of tissue-
specific gene expression (50, 51), were found. FREAC-4 has
recently been shown to be regulated by the c-Ets-1 proto-onco-
gene (51). Interestingly, a c-Ets-1 putative binding site was also
found in the Nas1 promoter region.
When placed upstream of a reporter gene, the Nas1 promoter
could initiate basal gene transcription in a cell-specific manner,
since the promoter was only active in OK cells and not in COS-1
or NIH3T3 cells, suggesting tissue specificity of promoter ac-
tivity. Only FREAC-4-binding sites were identified as potential
cis-acting elements associated with kidney-specific gene ex-
pression in this region, but their actual role in the cell-specific
expression of Nas1 remains unknown.
In a recent study, vitamin D was shown to modulate renal
Na1-sulfate cotransport (10). Vitamin D-deficient rats showed
lower plasma sulfate levels and an increased fractional excre-
tion of sulfate, which correlated with decreases in BBM Na1-
sulfate cotransport activity and rNaSi-1 protein and mRNA
abundance. Moreover, this modulation was shown to be the
result of a direct effect of vitamin D, with no independent
action of parathyroid hormone or calcium levels (10). The data
presented here extend these observations by demonstrating
that vitamin D and VDR/RXR transactivated the Nas1 pro-
moter in OK cells. A comparable transactivation by VDR and
1,25-(OH)2D3 was also observed for the renal Na
1-dependent
phosphate transporter gene, NPT2 (52). Our data suggest that
the previously reported effect of vitamin D on sulfate homeo-
stasis (10) may, at least in part, be mediated by a transcrip-
tional activation of the Nas1 gene. Although the first 1.2 kb of
Nas1 promoter is sufficient for vitamin D transactivation, we
cannot rule out that a further upstream region may play a role
in this phenomenon, and more detailed studies are required to
identify the specific VDRE loci in the Nas1 promoter.
Finally, the presence of five putative GREs and a typical
TRE in the Nas1 promoter may also be of significant impor-
tance for Nas1 gene regulation and hormonal control of sulfate
homeostasis. Glucocorticoids have been shown to regulate re-
nal Na1-sulfate cotransport at the BBM level (53), and exper-
imentally induced hypothyroidism in rats led to a decrease of
NaSi-1 mRNA and protein levels with no change in membrane
fluidity, suggesting a possible down-regulation of the Nas1
gene (54).
In summary, we have isolated and characterized the murine
Na1-sulfate cotransporter cDNA, gene, and promoter region.
In addition, we have investigated its expression in murine
tissues, determined its chromosomal localization, identified
cDNA variants, and demonstrated that this gene can be tran-
scriptionally activated by 1,25-(OH)2D3 in a renal cell line. This
study provides the framework for a more detailed analysis of
Nas1 gene expression through the characterization of Nas1
promoter function and the tools required for assessing the role
of Nas1 in the maintenance of sulfate homeostasis through the
generation and analysis of Nas1-deficient mice.
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